Oncomine Acute Myeloid Leukaemia AML Panel Test
Introduction
The Oncomine Acute Myeloid Leukaemia AML Panel Test is an advanced diagnostic tool designed to detect genetic mutations and alterations associated with acute myeloid leukaemia (AML). This test plays a vital role in the diagnosis and management of AML, allowing healthcare providers to tailor treatment strategies based on the specific genetic profile of the disease.
What the Test Measures
This panel test utilizes Next Generation Sequencing (NGS) technology to analyze multiple genes and fusion genes associated with AML, including but not limited to:
- ABL1
- ASXL1
- FLT3
- IDH1
- NPM1
- RUNX1
- …and many more.
Additionally, it assesses fusion genes like ETV6, JAK2, and MLL, which are crucial for understanding the molecular landscape of AML.
Who Should Consider This Test
Patients exhibiting symptoms such as unexplained fatigue, frequent infections, or easy bruising should consider the Oncomine AML Panel Test. It is particularly recommended for individuals with risk factors including:
- Family history of leukaemia
- Previous chemotherapy or radiation treatment
- Exposure to certain chemicals or radiation
Benefits of Taking the Test
Taking the Oncomine AML Panel Test offers numerous benefits:
- Accurate diagnosis of AML
- Identification of specific genetic mutations for tailored therapies
- Better prognostic information for treatment planning
- Guidance for clinical trial eligibility based on genetic findings
Understanding Your Results
Results from the Oncomine AML Panel Test will provide insights into the genetic mutations present in a patient’s cancer cells. These results can help guide treatment decisions and inform patients about their prognosis. It is essential to discuss the findings with a healthcare professional for an accurate interpretation.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Oncomine Acute Myeloid Leukaemia AML Panel Test | 819000 NGN | 910000 NGN |
Booking the Test
To schedule the Oncomine Acute Myeloid Leukaemia AML Panel Test, please contact us at +2348110567037. Ensure to complete the NGS Test Requisition Form (Form 40) prior to your appointment. Samples should be collected in a 3 mL (2 mL min.) whole blood or bone marrow in a lavender top (EDTA) tube, shipped refrigerated, and not frozen.
Our turnaround time is efficient, with samples collected on the 1st or 16th of each month, and reports delivered by the 15th or 30th of the same month.
For more information or to book your test, reach out to DNA Labs Nigeria today!
